Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme
Authors
Challapalli, A.Watkins, S.
Cogill, G.
Stewart, G.
Ellis, S.
Sykes, A.
Nobes, J.
Yip, K.
Barthakur, U.
Board, R.
Gadve, A.
O'Toole, L.
Kent, C.
Mackenzie, J.
Papa, S.
Fusi, A.
Fife, K.
Issue Date
2022
Metadata
Show full item recordCitation
Challapalli A, Watkins S, Cogill G, Stewart G, Ellis S, Sykes A, et al. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. J Eur Acad Dermatol Venereol. 2022.Journal
Journal of the European Academy of Dermatology and VenereologyDOI
10.1111/jdv.18082PubMed ID
35298050Additional Links
https://dx.doi.org/10.1111/jdv.18082Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1111/jdv.18082
Scopus Count
Collections
Related articles
- Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
- Authors: Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, Schadendorf D, Guminski A, Hauschild A, Wong DJ, Daniels GA, Berking C, Jankovic V, Stankevich E, Booth J, Li S, Weinreich DM, Yancopoulos GD, Lowy I, Fury MG, Rischin D
- Issue date: 2020 Feb
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
- Authors: Migden MR, Rischin D, Schmults CD, Guminski A, Hauschild A, Lewis KD, Chung CH, Hernandez-Aya L, Lim AM, Chang ALS, Rabinowits G, Thai AA, Dunn LA, Hughes BGM, Khushalani NI, Modi B, Schadendorf D, Gao B, Seebach F, Li S, Li J, Mathias M, Booth J, Mohan K, Stankevich E, Babiker HM, Brana I, Gil-Martin M, Homsi J, Johnson ML, Moreno V, Niu J, Owonikoko TK, Papadopoulos KP, Yancopoulos GD, Lowy I, Fury MG
- Issue date: 2018 Jul 26
- Oral ulcers and sarcoid-like reaction in lymph nodes after cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma: a case report.
- Authors: Ferreira MH, Bezinelli LM, Eduardo FP, Gobbi MF, Corrêa L, Schvartsman G
- Issue date: 2022
- Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
- Authors: Konidaris G, Paul E, Kuznik A, Keeping S, Chen CI, Sasane M, Xu Y, Atsou K, Ayers D, Ruiz ES, Khushalani NI, Cope S
- Issue date: 2021 Mar
- Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.
- Authors: Keeping S, Xu Y, Chen CI, Cope S, Mojebi A, Kuznik A, Konidaris G, Ayers D, Sasane M, Allen R, Huynh TM, Popoff E, Freeman M, Andria ML, Fury MG, Singh K, Stockfleth E, Challapalli A, Schmults CD
- Issue date: 2021 Feb